AstraZeneca Statistics
Total Valuation
AstraZeneca has a market cap or net worth of 209.59 billion. The enterprise value is 236.73 billion.
| Market Cap | 209.59B |
| Enterprise Value | 236.73B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Feb 20, 2025 |
Share Statistics
| Current Share Class | 1.55B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.54B |
Valuation Ratios
The trailing PE ratio is 26.97 and the forward PE ratio is 14.52.
| PE Ratio | 26.97 |
| Forward PE | 14.52 |
| PS Ratio | 3.81 |
| PB Ratio | 5.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.39, with an EV/FCF ratio of 21.23.
| EV / Earnings | 30.46 |
| EV / Sales | 4.19 |
| EV / EBITDA | 12.39 |
| EV / EBIT | 16.95 |
| EV / FCF | 21.23 |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.77.
| Current Ratio | 0.90 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 1.70 |
| Debt / FCF | 2.84 |
| Interest Coverage | 10.16 |
Financial Efficiency
Return on equity (ROE) is 19.79% and return on invested capital (ROIC) is 11.73%.
| Return on Equity (ROE) | 19.79% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 11.73% |
| Return on Capital Employed (ROCE) | 17.65% |
| Revenue Per Employee | 583,054 |
| Profits Per Employee | 82,418 |
| Employee Count | 94,300 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.23% in the last 52 weeks. The beta is 0.18, so AstraZeneca's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -13.23% |
| 50-Day Moving Average | 142.80 |
| 200-Day Moving Average | 145.65 |
| Relative Strength Index (RSI) | 45.47 |
| Average Volume (20 Days) | 1,995 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AstraZeneca had revenue of 54.98 billion and earned 7.77 billion in profits. Earnings per share was 4.97.
| Revenue | 54.98B |
| Gross Profit | 45.33B |
| Operating Income | 13.61B |
| Pretax Income | 9.29B |
| Net Income | 7.77B |
| EBITDA | 18.28B |
| EBIT | 13.61B |
| Earnings Per Share (EPS) | 4.97 |
Balance Sheet
The company has 5.40 billion in cash and 31.72 billion in debt, giving a net cash position of -26.32 billion.
| Cash & Cash Equivalents | 5.40B |
| Total Debt | 31.72B |
| Net Cash | -26.32B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 41.13B |
| Book Value Per Share | 26.48 |
| Working Capital | -2.99B |
Cash Flow
In the last 12 months, operating cash flow was 13.09 billion and capital expenditures -1.94 billion, giving a free cash flow of 11.15 billion.
| Operating Cash Flow | 13.09B |
| Capital Expenditures | -1.94B |
| Free Cash Flow | 11.15B |
| FCF Per Share | n/a |
Margins
Gross margin is 82.44%, with operating and profit margins of 24.75% and 14.14%.
| Gross Margin | 82.44% |
| Operating Margin | 24.75% |
| Pretax Margin | 16.90% |
| Profit Margin | 14.14% |
| EBITDA Margin | 33.24% |
| EBIT Margin | 24.75% |
| FCF Margin | 20.28% |
Dividends & Yields
This stock pays an annual dividend of 3.10, which amounts to a dividend yield of 2.29%.
| Dividend Per Share | 3.10 |
| Dividend Yield | 2.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 63.60% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 2.21% |
| Earnings Yield | 3.71% |
| FCF Yield | 5.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AstraZeneca has an Altman Z-Score of 3.08.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | n/a |